Michael Holder is of Cytek Biosciences, Inc.. Currently has a direct ownership of 3,635 shares of CTKB, which is worth approximately $21,373. The most recent transaction as insider was on Nov 18, 2024, when has been sold 2,181 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.64K
150.0% 3M change
n/a 12M change
Total Value Held $21,373

Michael Holder Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2024
BUY
Exercise of conversion of derivative security
-
2,181 Added 37.5%
3,635 Common Stock
Aug 19 2024
BUY
Exercise of conversion of derivative security
-
1,454 Added 50.0%
1,454 Common Stock

Also insider at

RCEL
AVITA Medical, Inc. Healthcare
MH

Michael Holder

Valencia, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB